Libros sobre el tema "Beta adrenergic receptor blockaders"

Siga este enlace para ver otros tipos de publicaciones sobre el tema: Beta adrenergic receptor blockaders.

Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros

Elija tipo de fuente:

Consulte los 25 mejores mejores libros para su investigación sobre el tema "Beta adrenergic receptor blockaders".

Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.

También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.

Explore libros sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.

1

Cruickshank, J. M. Beta-blockers in clinical practice. Edinburgh: Churchill Livingstone, 1988.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Prichard, Brian N. C. 1932-, ed. Beta-blockers in clinical practice. Edinburgh: Churchill Livingstone, 1987.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Drugs looking for diseases: Innovative drug research and the development of the beta blockers and the calcium antagonists. Dordrecht: Kluwer Academic Publishers, 1991.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Advances in adrenergic receptor biology. Amsterdam: Elsevier, 2011.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Owens, Helen. The effect of beta-adrenergic receptor antagonists on the temporal accommodative response. Birmingham: Aston University. Department of Vision Sciences, 1991.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

1944-, Costello J. F. y Mann Ronald D. 1928-, eds. Beta agonists in the treatment of asthma: The proceedings. Carnforth, Lancs, UK: Parthenon Pub. Group, 1992.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Richard, Beasley y Pearce Neil, eds. The Role of beta receptor agonist therapy in asthma mortality. Boca Raton: CRC Press, 1993.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

1946-, Frishman William H., ed. Beta₃-adrenergic agonism: A new concept in human pharmacotherapy. Armonk, N.Y: Futura, 1995.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Cruickshank, J. M. Beta-Blockers in Clinical Practice. 2a ed. W.B. Saunders Company, 1994.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

1948-, Deedwania Prakash C., ed. Beta-blockers and cardiac arrhythmias. New York: M. Dekker, 1992.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
11

1955-, Burch Ronald M., ed. Bradykinin antagonists: Basic and clinical research. New York: Dekker, 1991.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
12

H, Birkenhäger W., Folkow Björn y Struyker-Boudier H. A. J, eds. Adrenergic blood pressure regulation: Proceedings of a symposium, Corfu, 22-25 May 1984. Amsterdam: Excerpta Medica, 1985.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
13

R, Bühler Fritz, ed. The Cardioselectivity of bisoprolol. Montreal: PharmaLibri, 1989.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
14

The effect of training on beta adrenergic receptor number in rat heart. 1986.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
15

Beasley, Richard y Neil E. Pearce. Role of Beta Receptor Agonist Therapy in Asthma Mortality. Taylor & Francis Group, 2020.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
16

Beasley, Richard y Neil E. Pearce. Role of Beta Receptor Agonist Therapy in Asthma Mortality. Taylor & Francis Group, 2020.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
17

Beasley, Richard y Neil E. Pearce. Role of Beta Receptor Agonist Therapy in Asthma Mortality. Taylor & Francis Group, 2020.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
18

Pearce, Neil y Richard Beasley. Role of Beta Receptor Agonist Therapy in Asthma Mortality. Taylor & Francis Group, 2019.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
19

Beasley, Richard y Neil E. Pearce. Role of Beta Receptor Agonist Therapy in Asthma Mortality. Taylor & Francis Group, 2020.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
20

Frishman, William H. y Daniel E. Goldberg. Beta3 Adrenergic Agonism: A New Concept in Human Pharmacotherapy. Futura Publishing Company, 1995.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
21

Formoterol: A Long Acting B2-Agonist for the Management of Asthma : An International Symposium Held During the Joint Meeting of Sep and Sepcr, London. Hogrefe & Huber Pub, 1991.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
22

1936-, Saunders Kenneth B., European Society for Clinical Respiratory Physiology. y European Society of Pneumology, eds. Formoterol: A long-acting B2-agonist for the management of asthma : an international symposium held during the joint meeting of SEP and SEPCR, London, 1990. Seattle: Hogrefe & Huber, 1992.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
23

Formoterol. Hogrefe & Huber Pub, 1991.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
24

De Backer, Daniel y Patrick Biston. Vasopressors in critical illness. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199600830.003.0034.

Texto completo
Resumen
Vasopressors are used in various shock states to correct hypotension, aiming at restoring or improving organ and tissue perfusion. Vasopressor therapy may be associated with excessive vasoconstriction, but also metabolic and other side-effects. Hence, the ideal target for arterial pressure remains undetermined. Adrenergic agents remain the most commonly used vasopressor agents. Adrenergic agents increase arterial pressure through stimulation of alpha-adrenergic receptors. The effects of the different adrenergic agents differ mostly due to variable associated beta-adrenergic effects. Epinephrine and norepinephrine are strong and equipotent vasopressor agents. Their impact on outcome is as yet unanswered, but there is no sign that epinephrine might be associated with better outcomes. Accordingly, norepinephrine is the adrenergic agent of choice, especially in patients with cardiogenic shock. Vasopressin is a non-adrenergic vasopressor acting via V1 receptor stimulation, with weak vasopressor effects in normal conditions, but markedly increased vascular tone in shock states, especially in septic shock. Splanchnic vasoconstriction may occur. Arginine vasopressin at low doses appears to be a promising alternative to adrenergic agents, but its exact place is not yet well defined.
Los estilos APA, Harvard, Vancouver, ISO, etc.
25

1946-, Barnes Peter J., Matthys Heinrich y European Society of Pneumology. Congress, eds. Formoterol--a new-generation [beta] 2-agonist: An international symposium held during the 8th Congress of the European Society of Pneumology, Freiburg, Federal Republic of Germany, September 1989. Toronto: Hogrefe & Huber, 1991.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
Ofrecemos descuentos en todos los planes premium para autores cuyas obras están incluidas en selecciones literarias temáticas. ¡Contáctenos para obtener un código promocional único!

Pasar a la bibliografía